United States· US:55289-723_47e39c2d-9144-24b3-e063-6294a90a04d4
verapamil hydrochloride
A verapamil product containing verapamil hydrochloride, registered in United States by PD-Rx Pharmaceuticals, Inc.. The same ATC class is registered in 17 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Verapamil is registered in 17 of 19 countries.
Countries holding a registration under ATC C08DA01 (verapamil), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 10 of them publish a price we can compare per daily dose
Verapamil · ATC C08DA01
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of verapamil costs, country by country.
Normalised to the WHO defined daily dose (0.24 g), the median price runs from $0.21 in France to $0.95 in Switzerland — a ×4.6 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Verapamil · price per daily dose (0.24 g)
USD · FX 28 Sept 2026
- CH Switzerland$0.95
- IT Italy$0.31
- FR France$0.21
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- VERAPAMIL HYDROCHLORIDE
- Manufacturer
- PD-Rx Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- C08DA01
- ATC class
- Verapamil
- Defined daily dose
- 0.24 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc11552897233030 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (55289-723-30)
- ndc11552897239090 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (55289-723-90)
- ndc115528972393180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (55289-723-93)
- ndc1155289-723-93
- ndc1155289-723-30
- ndc1155289-723-90
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
467 interactions on record for verapamil.
Graded by severity as the source publishes them — 52 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Verapamil · interactions on record
467 records
- 52 severe
- 223 moderate
- 23 minor
- 143 info
Most severe, free to view
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- NaloxegolA06AH03severe
- LoperamideA07DA03severe
26 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Verapamil in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceISOPTINE L.P. 240 mg, comprimé pelliculé sécable à libération prolongéeVIATRIS MEDICAL
- United KingdomCordilox 120mg tabletsIVAX Pharmaceuticals UK Ltd
- FinlandChronoveraPharmacia Oy
- PolandIsoptin 40InPharm Sp. z o.o.
- GermanyIsoptinViatris Healthcare Gmbh
- CzechiaISOCOR
- NetherlandsIsoptin SR 120, tabletten met gereguleerde afgifte 120 mgViatris Healthcare B.V.
- SwedenIsoptin 40 mg Filmdragerad tablettViatris AB
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Isoptin, Isoptin Retard
- Belgium · Fibrocard, Isoptine
- Bulgaria · Верапамил Софарма, Верапамил Чайкафарма
- Cyprus · Akilen, Caveril
- Czechia · Isoptin, Isoptin Sr
- Germany · Isoptin, Isoptin Khk Retard
- Denmark · Isoptin Retard, Veraloc
- Estonia · Isoptin Retard, Verapamil Ratiopharm
- Spain · Manidón, Manidón Hta
- Finland · Isoptin Retard, Veramacor
- France · Isoptine, Isoptine L.P.
- United Kingdom (Northern Ireland) · Half Securon Sr, Securon Sr
- Greece · Isoptin
- Croatia · Isoptin, Isoptin Rr
- Hungary · Chinopamil, Isoptin
- Ireland · Isoptin, Isoptin Sr
- Iceland · Isoptin Retard, Veraloc Retard
- Italy · Isoptin, Verapamil Doc Generici
- Lithuania · Isoptin Retard, Verapamil Ratiopharm
- Luxembourg · Isoptin, Isoptin Khk Retard
- Latvia · Isoptin Retard
- Malta · Caveril, Isoptin
- Netherlands · Isoptin Sr, Verapamil Hcl Cf
- Norway · Isoptin, Isoptin Retard
- Poland · Isoptin 40, Isoptin 80
- Portugal · Isoptin, Isoptin Dc
- Romania · Cordamil, Isoptin Rr
- Sweden · Isoptin, Isoptin Retard
- Slovakia · Isoptin, Isoptin Ichs Retard
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dda1e4db-8f94-4f32-8342-a8dfe89c92d9 GET /v1/drugs/dda1e4db-8f94-4f32-8342-a8dfe89c92d9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "240",
"substance": "VERAPAMIL HYDROCHLORIDE",
"productndc": "55289-723",
"dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA078906",
"marketing_category": "ANDA"
}See everything about verapamil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.